// App-Quantinova.ai

39 : Development of a molecular profiling assay for circulating tumor cells (CTCs) utilizing automated multiplexed in situ hybridization for metastatic castrate-resistant prostate cancer (mCRPC).

Researchers

Presenter

  • Dea Nagy

Principal Investigators

  • Mateus Crespo

  • Gerhardt Attard

  • Ryan Dittamore

  • Susana Miranda

  • Karl Garsha

  • Ubaradka G. Sathyanarayana

  • Steve Yun

  • Michael Otter

  • Phillip Miller

  • Gary Pestano

  • Johann Sebastian De Bono

Medical Centers

  • The Institute of Cancer Research, Sutton, United Kingdom

  • The Institute of Cancer Research & The Royal Marsden, London, Spain

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Metastatic castration-resistant prostate cancer

Biomarkers

  • Phosphatase and tensin homolog

  • Circulating tumor cells

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved